COMPANY
MenoGeniX, Inc.
Timeline
- Trial start Phase 1: A Study of the Safety and Effect of Repeated Administration of G-CSF on Hot Flashes in Postmenopausal Women source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT03640754 | A Study of the Safety and Effect of Repeated Administration of G-CSF on Hot Flashes in Postmenopausal Women | Phase 1 | Completed | Aug 6, 2018 | Jan 21, 2022 (actual) |
NIH awards 3
- NIH award 1R43AG066538-01 FY2020: $299,831 awarded for that fiscal year; activity R43 (SBIR); PI EMLEN, JAMES WOODRUFF; recipient as written: MENOGENIX, INC., AURORA, CO. Expanded Clinical Trial of Granulocyte Colony source ↗
- NIH award 3R43AG056209-01A1S1 FY2019: $194,836 awarded for that fiscal year; activity R43 (SBIR); PI DUKE, RICHARD C; recipient as written: MENOGENIX, INC., AURORA, CO. Effect of Repeated Administration of G-CSF on H source ↗
- NIH award 1R43AG056209-01A1 FY2018: $693,360 awarded for that fiscal year; activity R43 (SBIR); PI DUKE, RICHARD C; recipient as written: MENOGENIX, INC., AURORA, CO. Effect of Repeated Administration of G-CSF on Hot source ↗